Literature DB >> 30711459

Live birth rates with a freeze-only strategy versus fresh embryo transfer: secondary analysis of a randomized clinical trial.

Lan N Vuong1, Toan D Pham2, Vinh Q Dang2, Tuong M Ho2, Vu N A Ho2, Robert J Norman3, Ben W Mol4.   

Abstract

RESEARCH QUESTION: What are the roles of serum progesterone and endometrial thickness as biomarkers in the decision between a freeze-only and fresh embryo transfer in IVF for women without polycystic ovary syndrome (PCOS)?
DESIGN: This was a secondary analysis of a randomized controlled trial including 782 couples who were followed up until the end of the first completed cycle. Couples scheduled for their first or second IVF cycle with a FSH/gonadotrophin-releasing hormone antagonist protocol were randomized to a freeze-only (n = 391) or fresh embryo transfer (n = 391) strategy. The endpoint for this analysis was live birth rate (LBR) after the first embryo transfer.
RESULTS: There was no significant difference in LBR after the first cycle between a freeze-only and fresh transfer strategy. When serum progesterone levels at trigger were in the third quartile (Q3, 1.14-1.53 ng/ml), LBR was significantly higher in the freeze-only versus fresh transfer group (P = 0.01); when serum progesterone was ≥1.14 ng/ml, LBR was significantly better in the freeze-only group (37.4% versus 23.8% in the fresh transfer group; P = 0.004). LBRs in the freeze-only and fresh embryo transfer groups were similar across all quartiles of endometrial thickness, although a small advantage for freeze-only in women with a very thin endometrium could not be excluded.
CONCLUSIONS: Serum progesterone level on the day of trigger may have potential as a biomarker on which to base a prospective decision about whether to use a freeze-only or fresh embryo transfer strategy in women undergoing IVF.
Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Biomarkers; Endometrial thickness; Freeze-only protocol; IVF; Progesterone; Randomized clinical trial

Mesh:

Substances:

Year:  2018        PMID: 30711459     DOI: 10.1016/j.rbmo.2018.12.012

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  4 in total

1.  Anti-Müllerian hormone in guiding the selection of a freeze-all versus a fresh embryo transfer strategy: a cohort study.

Authors:  Kai-Lun Hu; Rui Yang; Huiyu Xu; Ben W Mol; Rong Li; Rui Wang
Journal:  J Assist Reprod Genet       Date:  2022-07-23       Impact factor: 3.357

2.  Elective frozen embryo transfer (freeze-all): there seems to be no harm to transfer in the next immediate menstrual cycle.

Authors:  Matheus Roque; Sandro C Esteves
Journal:  Ann Transl Med       Date:  2020-08

3.  Improved clinical outcomes after non-invasive oocyte selection and Day 3 eSET in ICSI patients.

Authors:  Inge Van Vaerenbergh; Tom Adriaenssens; Wim Coucke; Lisbet Van Landuyt; Greta Verheyen; Michaël De Brucker; Michel Camus; Peter Platteau; Michel De Vos; Elien Van Hecke; André Rosenthal; Johan Smitz
Journal:  Reprod Biol Endocrinol       Date:  2021-02-19       Impact factor: 5.211

4.  Risk Factors for Different Types of Pregnancy Losses: Analysis of 15,210 Pregnancies After Embryo Transfer.

Authors:  Ai-Min Yang; Xiuhua Xu; Yan Han; Jian-Jun Wei; Gui-Min Hao; Na Cui; Zhi-Ming Zhao; Wei Wang; Xianghua Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-25       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.